Anti-Aging Treatments: How to Separate Clinical Evidence

What Counts as Convincing Evidence for an Anti-Aging Treatment?

Many potential longevity interventions begin with experiments in cells, laboratory animals or small groups of people. These studies can reveal biological mechanisms and guide further research, but findings in mice do not reliably establish that a treatment will prevent disability, dementia, cardiovascular disease or premature death in humans. Randomized controlled trials remain essential because they can reduce bias and compare benefits and harms against a placebo or appropriate standard of care.

Trials must also measure outcomes that matter to patients. A change in a molecular pathway, inflammatory marker or biological-age estimate is not automatically evidence of better health. Researchers may examine physical function, the development of major chronic diseases, quality of life, hospitalization and survival while monitoring adverse effects over sufficient time. Replication by independent groups and enrollment of participants with varied ages, health conditions and backgrounds make results more clinically useful.

Can Biological-Age Tests Prove That a Longevity Therapy Works?

Epigenetic clocks, protein patterns and other aging biomarkers attempt to describe biological changes associated with age. They may help researchers identify risk or determine whether an intervention affects a particular pathway. However, different tests can produce different estimates, and it remains uncertain whether changing a score changes the underlying risk of disease or merely alters the marker being measured.

A biomarker becomes a reliable surrogate endpoint only after strong evidence shows that its treatment-related change predicts a meaningful clinical benefit. Aging clocks have not yet reached that standard for routine treatment decisions or regulatory approval. Consumers should therefore be cautious when commercial programs use a single before-and-after test to claim rejuvenation, especially when testing methods, measurement variability and conflicts of interest are not disclosed.

What Can People Do Now to Support Healthy Aging?

Current evidence supports regular physical activity, adequate sleep, avoiding tobacco, maintaining social connection and following a nutritious dietary pattern. Managing blood pressure, cholesterol and diabetes risk can also reduce the burden of diseases that commonly impair health later in life. Vaccination, cancer screening and other preventive services should be individualized with a qualified healthcare professional.

Drugs promoted for longevity may have legitimate approved uses while carrying meaningful risks when taken without an appropriate indication. Dietary supplements are not reviewed by the FDA for effectiveness before marketing in the same way as prescription drugs, and products can interact with medicines or vary in composition. People considering an anti-aging intervention should ask whether it has been tested in randomized human trials, whether the reported outcome matters clinically and whether harms were monitored for long enough.